Association of baseline symptom burden with efficacy outcomes: Exploratory analysis from the randomized phase III REVEL study in advanced non-small-cell lung cancer

Lung Cancer ◽

10.1016/j.lungcan.2019.03.001 ◽

2019 ◽

Vol 131 ◽

pp. 6-13 ◽

Author(s):

Maurice Pérol ◽

Katherine B. Winfree ◽

Gebra Cuyun Carter ◽

Zhanglin Lin Cui ◽

Lee Bowman ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Symptom Burden ◽

Exploratory Analysis ◽

Phase Iii ◽

Small Cell Lung

Download Full-text

Cmet Expression and Activity of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (Nsclc) Patients (Pts): Exploratory Analysis of the Randomized Phase III Torch Trial

Annals of Oncology ◽

10.1093/annonc/mdu349.28 ◽

2014 ◽

Vol 25 ◽

pp. iv438

Author(s):

M. Tsao ◽

M. Di Maio ◽

L. Kim ◽

G. Liu ◽

J. Xu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Exploratory Analysis ◽

Phase Iii ◽

Small Cell Lung ◽

Nsclc Patients ◽

Expression And Activity

Download Full-text

Post study docetaxel in non-small cell lung cancer (NSCLC) patients after discontinuation from a randomized phase III trial of pemetrexed versus docetaxel: An exploratory analysis

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7135 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7135-7135 ◽

Author(s):

J.-L. Pujol ◽

S. Shaharyar ◽

C. Kortsik ◽

M. F. Wu ◽

C. Bagnes ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Exploratory Analysis ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Download Full-text

Post study docetaxel in non-small cell lung cancer (NSCLC) patients after discontinuation from a randomized phase III trial of pemetrexed versus docetaxel: An exploratory analysis

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.7135 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7135-7135 ◽

Author(s):

J.-L. Pujol ◽

S. Shaharyar ◽

C. Kortsik ◽

M. F. Wu ◽

C. Bagnes ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Exploratory Analysis ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Download Full-text

3073 Exploratory analysis of frontline therapies in REVEL: A randomized phase III study of ramucirumab (RAM) plus docetaxel (DOC) versus DOC for the treatment of stage IV non-small-cell lung cancer (NSCLC) after disease progression on platinum-based therapy

European Journal of Cancer ◽

10.1016/s0959-8049(16)31714-2 ◽

2015 ◽

Vol 51 ◽

pp. S621

Author(s):

E.B. Garon ◽

G.V. Scagliotti ◽

O. Gautschi ◽

M. Reck ◽

M. Thomas ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Disease Progression ◽

Cell Lung Cancer ◽

Stage Iv ◽

Exploratory Analysis ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text

Phase III Study Comparing Oral Topotecan to Intravenous Docetaxel in Patients With Pretreated Advanced Non–Small-Cell Lung Cancer

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70422-6 ◽

2007 ◽

Vol 2007 ◽

pp. 206-207

Author(s):

N.H. Hanna

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study ◽

Download Full-text

Phase III trial of cisplatin/gemcitabine with or without vinorelbine or paclitaxel in advanced non[ndash ]small cell lung cancer

Seminars in Oncology ◽

10.1053/sonc.2001.24366 ◽

2001 ◽

Vol 28 (2D) ◽

pp. 7-10

Author(s):

Pasquale Comella

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Trial

Download Full-text

Phase III study of vinflunine versus docetaxel in patients (pts) with advanced non-small cell lung cancer (NSCLC) previously treated with a platinum-containig regimen

Pneumologie ◽

10.1055/s-2008-1074239 ◽

2008 ◽

Vol 62 (S 2) ◽

Author(s):

J von Pawel ◽

M Reck ◽

R Ramlau ◽

J Jassem ◽

P Zatloukal ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study ◽

Previously Treated

Download Full-text

Faculty Opinions recommendation of Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1120004.586903 ◽

2008 ◽

Author(s):

Daniel Vorobiof ◽

Keo Tabane

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Advanced Stage ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text

Faculty Opinions recommendation of Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13649956.15438060 ◽

2012 ◽

Author(s):

Paul Van Schil

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text

Faculty Opinions recommendation of Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.3756959.3483058 ◽

2010 ◽

Author(s):

Thomas Stinchcombe

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Multicenter Trial ◽

Phase Iii ◽

Small Cell Lung

Download Full-text